- Home
- JCTC vs RLYB Comparison
JCTC vs RLYB Comparison
Compare JCTC & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCTC
- RLYB
- Stock Information
- Founded
- JCTC 1953
- RLYB 2018
- Country
- JCTC United States
- RLYB United States
- Employees
- JCTC N/A
- RLYB N/A
- Industry
- JCTC
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- JCTC
- RLYB Health Care
- Exchange
- JCTC NYSE
- RLYB Nasdaq
- Market Cap
- JCTC 13.8M
- RLYB 13.3M
- IPO Year
- JCTC 1996
- RLYB 2021
- Fundamental
- Price
- JCTC $3.90
- RLYB $0.29
- Analyst Decision
- JCTC
- RLYB Hold
- Analyst Count
- JCTC 0
- RLYB 4
- Target Price
- JCTC N/A
- RLYB $15.00
- AVG Volume (30 Days)
- JCTC 12.4K
- RLYB 86.0K
- Earning Date
- JCTC 04-14-2025
- RLYB 05-08-2025
- Dividend Yield
- JCTC N/A
- RLYB N/A
- EPS Growth
- JCTC N/A
- RLYB N/A
- EPS
- JCTC N/A
- RLYB N/A
- Revenue
- JCTC $47,432,094.00
- RLYB $848,000.00
- Revenue This Year
- JCTC N/A
- RLYB N/A
- Revenue Next Year
- JCTC N/A
- RLYB N/A
- P/E Ratio
- JCTC N/A
- RLYB N/A
- Revenue Growth
- JCTC N/A
- RLYB N/A
- 52 Week Low
- JCTC $3.26
- RLYB $0.22
- 52 Week High
- JCTC $5.69
- RLYB $2.00
- Technical
- Relative Strength Index (RSI)
- JCTC N/A
- RLYB 35.98
- Support Level
- JCTC N/A
- RLYB $0.29
- Resistance Level
- JCTC N/A
- RLYB $0.33
- Average True Range (ATR)
- JCTC 0.00
- RLYB 0.02
- MACD
- JCTC 0.00
- RLYB 0.02
- Stochastic Oscillator
- JCTC 0.00
- RLYB 42.19
About JCTC JEWETT-CAMERON TRADING CO
Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.